Clinical trial
A Single-Blind, Placebo Run-in, Phase I/II Study Comparing Five Oral Doses of Proellex®
NCT01187043 is registered in ClinicalTrials.gov with Repros Therapeutics Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single-Blind, Placebo Run-in, Phase I/II Study Comparing Five Oral Doses of Proellex®
- Lead sponsor
- Repros Therapeutics Inc.
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- August 31, 2010
- Completion date
- March 31, 2012
- Enrollment
- 52 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.